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Introduction
Cardiovascular disease has a complex etiology, and
there is no single cause. The risk of dying from compli-
cations arising from cardiovascular disease is higher 
in industrialized nations than in developing countries
[1]. This is related in large part to the lifestyle of afflu-
ence. Rapid economic development has accompanied
lifestyle changes during recent years in Taiwan, and
cardiovascular disease has become the second leading
cause of death in women [2]. Traditionally, cardiovas-
cular disease management strategies have focused on
treating patients with the disease. However, it is now
known that the disease process begins early in life. Thus,
primary prevention is important for presymptomatic
people.
Several biochemical markers have been identified
as risk factors for cardiovascular disease, including 
elevated levels of serum low-density lipoprotein cho-
lesterol (LDL-C), total cholesterol, triglycerides (TG),
homocysteine (Hcy), high-sensitivity C-reactive protein
(hsCRP) and insulin, as well as reduced levels of high-
density lipoprotein cholesterol (HDL-C). Obesity is
associated with an adverse effect on each of these risk
factors and increases the risk of cardiovascular disease.
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SUMMARY
Objective: The aim of this study was to evaluate the effects of a weight reduction lifestyle program on risk 
factors for cardiovascular disease in women.
Materials and Methods: The present study was a pilot clinical trial designed to test the effects of a weight
reduction lifestyle program on risk factors for cardiovascular disease in women. Obese and overweight women
were recruited from April 2006 to November 2006. The data collected included age, body weight, body mass
index (BMI), abdominal circumference, hip circumference, serum lipid profile, as well as levels of high-sensitivity
C-reactive protein and homocysteine. The subjects underwent a 3-month lifestyle program, including diet edu-
cation, balanced diet with caloric restriction of 1,200 kcal/day, aerobic exercise (1 hour) twice weekly and jogging
for at least 10,000 steps daily. Physical examination and blood tests were performed at the beginning and at the
end of the study.
Results: A total of 29 subjects were included in the present study. Significant reductions were observed in body
weight, BMI, abdominal circumference, hip circumference, systolic blood pressure, diastolic blood pressure,
fasting insulin, total cholesterol, low-density lipoprotein cholesterol, triglycerides and high-sensitivity C-reactive
protein. No significant differences were observed in the levels of fasting sugar, high-density lipoprotein cholesterol
or homocysteine.
Conclusion: An appropriate weight reduction lifestyle program may effectively reduce body weight and decrease
most of the risk factors for cardiovascular disease. [Taiwan J Obstet Gynecol 2009;48(1):49–52]
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Thus, weight loss generally results in beneficial effects
on many risk factors. However, there is limited data
about the beneficial effects of weight loss in Taiwanese
women.
The primary purpose of this study was to examine
the effects of a weight reduction lifestyle program on
risk factors for cardiovascular disease in women.
Materials and Methods
The present study was a pilot clinical trial designed to
test the effects of a weight reduction lifestyle program
on the risk factors for cardiovascular disease in women.
Participants and protocol
Obese and overweight women were recruited from
April 2006 to November 2006 at the women’s weight
control clinic in the Taiwan Adventist Hospital. The
study was approved by the institutional research board.
The subjects underwent medical evaluations designed
to identify contraindications to diet, exercise, or both,
including history of myocardial infarction, cerebrovas-
cular, kidney or liver disease, as well as cancer, diabetes
mellitus, pregnancy and the use of medications known
to affect weight or energy expenditure.
The subjects underwent a 3-month lifestyle pro-
gram, which consisted of diet education, compliance to
a balanced diet with a caloric restriction of 1,200 kcal/
day, 1 hour of aerobic exercise twice weekly, and jogging
for at least 10,000 steps daily.
Physical examinations and blood tests were per-
formed at the beginning and at the end of the study.
The data collected included age, body weight (BW),
body height (BH), abdominal circumference (AC), hip
circumference (HC), body mass index (BMI; BW in
kilograms divided by the square of height in meters),
systolic blood pressure (SBP), diastolic blood pressure
(DBP), serum levels of hsCRP, fasting glucose levels,
fasting insulin levels, LDL-C, HDL-C, TG and Hcy.
The measurements of anthropometric indices were
carried out at the physical examination center in the
Taiwan Adventist Hospital by an internist. Overweight
was defined as BMI > 24 kg/m2 and < 27 kg/m2, and
obesity as BMI > 27 kg/m2.
Laboratory measurements
Blood samples were obtained after an overnight fast-
ing period of 8 hours. Levels of fasting blood glucose,
TG, HDL-C and LDL-C were measured using commer-
cial kits on an automatic analyzer (Synchron CX9;
Beckman Coulter Co., Fullerton, CA, USA). Insulin 
levels were also determined using commercial kits on
an automated analyzer (Access Immunoassay System;
Beckman Coulter Co.). HsCRP concentrations were
measured using a solid-phase, chemiluminescent immu-
nometric assay (Immulite 2000; Diagnostic Product
Corp., Los Angeles, CA, USA) with a sensitivity of
0.01 mg/dL.
Statistical analysis
All data are presented as means and standard devia-
tions. Comparisons between the pre-program and post-
program data were performed using the paired t test.
The level of significance was set at p < 0.05.
Results
A total of 29 subjects with a mean age of 44.3 ± 10.5
years, weight of 77.8 ± 11.7 kg, height of 156.5 ± 5.4 cm,
and BMI of 31.8 ± 4.1 completed the 3-month program.
The effects of the program on cardiovascular disease
risk factors in women are shown in the Table.
Anthropometric and physical characteristics
BW, BMI, AC, HC and hsCRP were significantly reduced
following 3 months of diet control and exercise. The
intervention also significantly lowered SBP and DBP.
There were no significant differences in Hcy.
Blood lipoproteins
Three months of diet control and exercise induced
weight loss which resulted in significant reductions in
total cholesterol, TG and LDL-C. Lipid profile para-
meters changed as follows: total cholesterol decreased
11.31%, LDL-C decreased 11.41%, and TG decreased
24.60%. HDL-C was not significantly altered by the
interventions.
Glucose homeostasis
Twenty-four percent (7/29) of subjects had baseline
fasting insulin concentrations above 10.0 IU/mL (range,
1.2–28.4 IU/mL). Four patients (13.8%) had insulin re-
sistance with homeostasis model assessment (HOMA)
≥ 3.8. Fasting insulin (8.2 ± 7.0 vs. 6.3 ± 4.5 IU/mL) was
significantly reduced from baseline after weight loss.
AC, fasting sugar and HOMA (2.04 ± 1.87 vs. 1.53 ±
1.12) were not significantly reduced after participation
in the weight loss program.
Discussion
During the past two decades, women in Taiwan have
adopted a Western lifestyle. Consumption of high-fat
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foods and decreased physical activity can easily cause
women to become obese. It is now recognized that
obesity is associated with increased risk of cardiovas-
cular disease. Specifically, an increase in abdominal fat
has been related to hyperinsulinemia, dyslipidemia and
cardiovascular disease.
There have been numerous studies conducted to
identify the risk factors for cardiovascular disease. These
risk factors can be divided into those that can be modi-
fied and those that cannot. Non-modifiable risk factors
include age, gender, and certain genetic mutations. The
modifiable risk factors include BMI, exercise, high blood
pressure, dyslipidemia, and insulin resistance [1].
After reviewing the literature, our findings here of
the risk factors for cardiovascular disease in Taiwan are
generally consistent with the findings in the West [2].
Sedentary lifestyle, low HDL-C, and high LDL-C and
TG contribute to the risk of coronary heart disease.
During the past three decades, numerous studies have
demonstrated that lifestyle intervention results in the
improvement in blood lipid profiles and BMI [3]. How-
ever, there have been few studies on women in Taiwan.
The present study is the first to report the efficiency of
a weight loss lifestyle program in improving women’s
health in Taiwan. Participants were studied before and
after weight loss, which allowed us to assess the mag-
nitude of change in cardiovascular disease risk factors
in response to a 3-month lifestyle program.
After the treatment period, we found significantly
decreased BW. This is predicted to improve health,
since accumulation of fat in the abdominal region is
associated with a variety of metabolic diseases. SBP
and DBP decreased significantly after the 3-month
treatment period. Again, our current findings are in
agreement with most published results [3,4].
Significant reductions in TG, total cholesterol and
LDL-C were observed after participation in the lifestyle
program. These findings are consistent with other pub-
lished results [5,6]. As for the so-called “good” lipopro-
tein HDL-C, it was decreased 3% from baseline. However,
we do not believe that a reduction in the HDL-C level is
a cause for concern. The reasons are as follows: a meta-
analysis stated that HDL-C levels decreased during
weight loss, but increased by 0.009 mmol/L for every
kilogram reduction in BW once patients reached a sta-
ble, reduced BW [7]. Another meta-analysis stated
that the average net increase in HDL-C levels using
exercise itself was modest but highly significant [8].
In addition to the lipid profiles, baseline hsCRP
concentration was shown to be an independent risk
factor for cardiovascular disease among apparently
healthy middle-aged women [9,10]. The results of our
study showed that serum levels of hsCRP decreased
after diet control and aerobic exercise.
Another cardiovascular disease risk factor, Hcy, is
believed to be increased after weight loss, which may
be the result of inadequate intake of folic acid [11,12].
The weight loss program in our study did not signifi-
cantly affect serum Hcy. This might be because of the
balanced diet in our study. Therefore, emphasis on foods
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Table. Anthropometric indices and risk factors before and after the lifestyle program*
Pre-program Post-program p Change (%)
Age (yr) 44.3 ± 10.5
Body height (cm) 156.5 ± 5.4
Body weight (kg) 77.8 ± 11.7 73.6 ± 10.6 < 0.001 −5.35
BMI (kg/m2) 31.8 ± 4.1 30.1 ± 4.0 < 0.001 −5.35
AC (cm) 38.3 ± 4.5 36.3 ± 4.2 < 0.001 −5.22
HC (cm) 43.7 ± 3.3 42.0 ± 3.1 < 0.001 −3.89
SBP (mmHg) 128.3 ± 17.2 122.2 ± 14.7 0.003 −4.75
DBP (mmHg) 77.8 ± 11.0 74.6 ± 11.8 0.02 −4.11
Fasting sugar (mg/dL) 97.0 ± 9.8 96.3 ± 9.3 0.32 −0.722
Fasting insulin (IU/mL) 8.2 ± 7.0 6.3 ± 4.5 0.046 −23.17
Total cholesterol (mg/dL) 210.4 ± 42.1 186.6 ± 32.7 < 0.001 −11.31
HDL-C (mg/dL) 48.0 ± 8.4 46.5 ± 8.6 0.16 −3.13
LDL-C (mg/dL) 134.1 ± 35.6 118.8 ± 28.8 < 0.001 −11.4
Triglyceride (mg/dL) 141.5 ± 58.7 106.7 ± 53.0 < 0.001 −24.59
Hs-CRP (mg/dL) 0.43 ± 3.02 0.29 ± 0.04 0.003 −32.56
Homocysteine (mg/dL) 14.0 ± 3.8 14.9 ± 2.8 0.09 6.43
HOMA 2.04 ± 1.87 1.53 ± 1.12 0.21 −33.33
*Data are presented as mean ± standard deviation. BMI = body mass index; AC = abdominal circumference; HC = hip circumference; SBP = systolic blood 
pressure; DBP = diastolic blood pressure; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; Hs-CRP = high-sensitivity 
C-reactive protein; HOMA = homeostasis model assessment.
rich in folic acid may be an important component of 
a weight loss program to prevent an increase in Hcy [13].
In addition to traditional risk factors, epidemiologic
studies have suggested an increased risk of cardiovascu-
lar disease in individuals with impaired glucose tolerance
and insulin resistance [14]. Fasting insulin concentra-
tion was reduced in participants in our program; how-
ever, fasting glucose and insulin resistance (sensitivity)
were not significantly altered. On the contrary, findings
from other studies showed improvements in insulin sen-
sitivity [15,16]. A possible explanation for this discrep-
ancy might be the total exercise duration (120 minutes/
week vs. ∼170 minutes/week) and program period 
(3 months vs. 4–6 months).
However, several potential limitations affect the
interpretation of the results. The most important is 
the relatively small sample size and lack of a control
group. Second, the duration of follow-up was short.
We did not have results from different treatment peri-
ods to compare the differences between programs of
different durations. Without the long-term cardiovas-
cular disease risk factor evaluation, we do not know
how long the “good effect” will last. In addition, there
have been few baseline hsCRP evaluations in Taiwanese
women [17]. We need more subjects and a long-term
follow-up to confirm the beneficial effects of this 
program.
In conclusion, this pilot study indicated that a
weight reduction lifestyle program improves most risk
factors of cardiovascular disease in women. It provides
a practical approach to prevent cardiovascular events
in women.
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